FANGZHOU JIANKE: 2024 Annual Report

HKEXApr 23 04:56 ET · Announcements

Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models

PR NewswireApr 9 23:07 ET

Fangzhou Widens Loss in 2024

MT NewswiresMar 24 05:22 ET

Express News | Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation

ReutersMar 23 23:01 ET

Press Release: Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation

Dow JonesMar 23 23:01 ET

Ark Health's stock price rose over 8%. The revenue for 2024 is 2.707 billion yuan, an increase of 11.2% year-on-year.

Ark Health (06086) saw its stock price rise by 8.67% after the earnings report, currently at HK$5.89, with a trading volume of HK$13.1188 million. On March 23, Ark Health (06086) released its performance announcement for the year ending December 31, 2024. In 2024, the company's revenue is expected to grow by 11.2% compared to 2023, reaching 2.707 billion yuan, mainly benefiting from increases in revenue from offline retail pharmacy services, wholesale, and customized content and marketing solutions.

Sina H-shares.Mar 23 21:34 ET